BACAX | VENAX | BACAX / VENAX | |
Total Expense Ratio | 1.32 | 0.09 | 1,467% |
Annual Report Gross Expense Ratio | 1.36 | 0.09 | 1,511% |
Fund Existence | 20 years | 21 years | - |
Gain YTD | 5.800 | 0.921 | 630% |
Front Load | 5% | N/A | - |
Min. Initial Investment | 1000 | 100000 | 1% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 278M | 8.11B | 3% |
Annual Yield % from dividends | 2.20 | 3.27 | 67% |
Returns for 1 year | -0.80 | -4.70 | 17% |
Returns for 3 years | 29.27 | 21.52 | 136% |
Returns for 5 years | 143.95 | 146.87 | 98% |
Returns for 10 years | 44.94 | 17.86 | 252% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
GCTCX | 44.65 | 0.39 | +0.88% |
Goldman Sachs US Tax-Managed Eq C | |||
RWIEX | 71.37 | 0.45 | +0.63% |
American Funds Capital World Gr&Inc R4 | |||
HMVSX | 17.79 | 0.08 | +0.45% |
Hartford MidCap Value R4 | |||
SWRLX | 18.22 | 0.05 | +0.28% |
Touchstone International Value A | |||
LICQX | 17.40 | 0.01 | +0.06% |
Lord Abbett International Equity R2 |